Design Therapeutics, Inc.
DSGN
$14.83
$0.443.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.17M | -17.64M | -16.00M | -17.00M | -19.08M |
| Total Depreciation and Amortization | 151.00K | 157.00K | 156.00K | 155.00K | 152.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.93M | 3.85M | 2.92M | 2.82M | 3.50M |
| Change in Net Operating Assets | 564.00K | -2.80M | 960.00K | 2.86M | 994.00K |
| Cash from Operations | -15.52M | -16.43M | -11.97M | -11.16M | -14.44M |
| Capital Expenditure | -21.00K | -- | -34.00K | 0.00 | -87.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.08M | -7.59M | -11.55M | 6.51M | 20.20M |
| Cash from Investing | 15.06M | -7.59M | -11.58M | 6.51M | 20.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 605.00K | 19.93M | 25.32M | 37.00K | 361.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 605.00K | 19.93M | 25.32M | 37.00K | 361.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.00K | -4.09M | 1.77M | -4.62M | 6.04M |